Is the AIDS virus a science fiction?

Duesberg, Peter H.; Ellison, Bryan J.
June 1990
Policy Review;Summer90, Issue 53, p40
Academic Journal
Explores immunosuppressive behavior as possible cause of AIDS. Earliest proposed causes of AIDS; Centers for Disease Control's (CDC) report describing unusual medical cases with confirmed immunosuppression; Cases showing similar severe immune suppression problems; Criticisms against the HIV hypothesis; Risk-AIDS hypothesis; Zidovudine (AZT) toxicity; Misguided programs.


Related Articles

  • Coccidioidomycosis-associated Deaths, United States, 1990-2008. Huang, Jennifer Y.; Bristow, Benjamin; Shafir, Shira; Sorvillo, Frank // Emerging Infectious Diseases;Nov2012, Vol. 18 Issue 11, p1723 

    Coccidioidomycosis is endemic to the Americas; however, data on deaths caused by this disease are limited. To determine the rate of coccidioidomycosis-associated deaths in the United States, we examined multiple cause-coded death records for 1990-2008 for demographics, secular trends, and...

  • HIV/AIDS Education: Still an Important Issue for Veterinarians. Davis, Radford G. // Public Health Reports;May/Jun2008, Vol. 123 Issue 3, p266 

    Human immunodeficiency virus (HIV)/acquired immunodeficiency syndrome (AIDS) is a significant cause of immunosuppression that puts infected individuals at higher risk for developing severe complications from zoonotic infections and other animal-related hazards. The number of people living with...

  • Lack of adaptation to human tetherin in HIV-1 Group O and P.  // Retrovirology;2011, Vol. 8 Issue 1, p78 

    The article offers information on a research that studies the adaptation behavior towards human tetherin in human immunodeficiency virus-1 (HIV-1) belonging to groups O and P. It is mentioned that HIV-1 viruses are divided into four groups namely, M, N, O and P and only group M viruses causes...

  • Blockade of chemokine-induced signalling inhibits CCR5-dependent HIV infection in vitro without blocking gp120/CCR5 interaction. Grainger, David J.; Lever, Andrew M. L. // Retrovirology;2005, Vol. 2, p1 

    Background: Cellular infection with human immunodeficiency virus (HIV) both in vitro and in vivo requires a member of the chemokine receptor family to act as a co-receptor for viral entry. However, it is presently unclear to what extent the interaction of HIV proteins with chemokine receptors...

  • Introduction of HIV into drug injector networks outside AIDS epicentres. Williams, Mark L.; Zixian Zhao; Bowen, Anne M.; Freeman, Robert C.; Elwood, William N.; Rusek, Ryan; Williams, M L; Zhao, Z; Bowen, A M; Freeman, R C; Elwood, W N; Rusek, R // International Journal of STD & AIDS;Oct1997, Vol. 8 Issue 10, p629 

    Injection drug users (IDUs) continue to be at risk for HIV infection despite high levels of knowledge about how human immunodeficiency virus/acquired immunodeficiency syndrome (HIV/AIDS) is transmitted. Yet, among not-in-treatment injection drug users, the chances of becoming infected with HIV...

  • The need for development assistance for health in the eastern European Region. McKee, Martin // Bulletin of the World Health Organization;Dec2005, Vol. 83 Issue 12, p883 

    The article presents information on the poor condition of the health care system in the Eastern European region. It requires developmental assistance to elevate the health condition of the people inhabiting the region . The period 1950-80 has seen a massive increase in human immunodeficiency...

  • Immunosuppressive Drugs in HIV Disease. Argyropoulos, Christos; Mouzaki, Athanasia // Current Topics in Medicinal Chemistry;Aug2006, Vol. 6 Issue 16, p1769 

    Hyper activation of the immune system has emerged as an important clinical marker of HIV disease progression to AIDS. During the chronic phase of the disease, chronic immune activation is linked to systemic CD4 T-cell depletion and eventual immune failure. Additionally, the HIV virus per se...

  • Progressive multifocal leukoencephalopathy in the AIDS era. Berger, Joseph R. // Journal of NeuroVirology;Apr2004 Supplement 2, Vol. 10, p37 

    As a consequence of the AIDS pandemic, PML has ceased to be a rare disease. Approximately 5% of the HIV-infected population will ultimately develop PML. HIV relative to other immunosuppressive conditions remain undetermined, but may be related to the nature and degree of immunodeficiency,...

  • HIV Type 2 in New York City, 2000-2008. Torian, Lucia V.; Eavey, Joanna J.; Punsalang, Amado P.; Pirillo, Robert E.; Forgione, Lisa A.; Kent, Scott A.; Oleszko, William R. // Clinical Infectious Diseases;12/1/2010, Vol. 51 Issue 11, p1334 

    Background. Antibody cross-reactivity complicates differential diagnosis of human immunodeficiency virus (HIV) type 2 (HIV-2) using standard serologic screening and confirmatory tests for HIV. HIV type 1 (HIV-1) viral load testing does not detect HIV-2. Although HIV-2 is, in general, less...


Read the Article


Sorry, but this item is not currently available from your library.

Try another library?
Sign out of this library

Other Topics